QDEL:NASDAQ
Quidelortho Corp
$13.99
arrow_upward
+1.75%(+0.24) 1D
$13.72
arrow_downward
-1.93% (-0.27)bedtimeAfter hours
Closed: Aug 11, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
$13.58
High
$14.24
Low
$13.28
Mkt. cap
959.37M
Avg. vol.
1.58M
Volume
1.50M
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.68
Shares outstanding
68.58M
No. of employees
6K
Open
$13.58
High
$14.24
Low
$13.28
Mkt. cap
959.37M
Avg. vol.
1.58M
Volume
1.50M
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.68
Shares outstanding
68.58M
No. of employees
6K
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
QDEL Q2 Earnings & Revenues Beat Estimates, 2026 Guidance Lowered
Stock Traders Daily
·
3 days ago
Avoiding Lag: Real-Time Signals in (QDEL) Movement
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6.5K
Founded1979
HeadquartersSan Diego, California, United States
SectorMedical device
Websitequidelortho.com
AI content may include mistakes. Learn more